Whitebox Advisors’s enGene Therapeutics Warrants ENGNW Stock Holding History

Whitebox Advisors’s Portfolio ENGNW Stock Details ENGNW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-31,000	Closed	-$22K	–	507
2025 Q3	$22K	Hold	31,000	–	–	﹤0.01%	369
2025 Q2	$25.4K	Hold	31,000	–	–	﹤0.01%	328
2025 Q1	$18.6K	Sell	31,000 -2,333	-7%	-$1.92K	﹤0.01%	253
2024 Q4	$28.1K	Hold	33,333	–	–	﹤0.01%	197
2024 Q3	$70K	Hold	33,333	–	–	﹤0.01%	179
2024 Q2	$39.7K	Hold	33,333	–	–	﹤0.01%	190
2024 Q1	$173K	Hold	33,333	–	–	0.01%	162
2023 Q4	$28.3K	Buy	+33,333	New	+$25.6K	﹤0.01%	146

Other funds holding ENGNW

FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Caption Management Oklahoma City, Oklahoma $2.1B AUM 70.99% 1-Year Est. Return

Calamos Advisors

Calamos Advisors Naperville, Illinois $25.9B AUM 21.78% 1-Year Est. Return

Saba Capital Management New York $3.12B AUM 13% 1-Year Est. Return

D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return

LMR Partners London, United Kingdom $10.9B AUM 60.68% 1-Year Est. Return

Tenor Capital Management New York $6.49B AUM 3.01% 1-Year Est. Return

Blue Owl Capital Holdings New York $369M AUM 78.25% 1-Year Est. Return